CA2101310C - Novel arylglycinamide derivatives and preparative processes therefor - Google Patents

Novel arylglycinamide derivatives and preparative processes therefor Download PDF

Info

Publication number
CA2101310C
CA2101310C CA002101310A CA2101310A CA2101310C CA 2101310 C CA2101310 C CA 2101310C CA 002101310 A CA002101310 A CA 002101310A CA 2101310 A CA2101310 A CA 2101310A CA 2101310 C CA2101310 C CA 2101310C
Authority
CA
Canada
Prior art keywords
group
carbon atoms
lower alkyl
denotes
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002101310A
Other languages
English (en)
French (fr)
Other versions
CA2101310A1 (en
Inventor
Hiroyuki Miyachi
Mitsuru Segawa
Emiko Tagami
Hideo Okubo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of CA2101310A1 publication Critical patent/CA2101310A1/en
Application granted granted Critical
Publication of CA2101310C publication Critical patent/CA2101310C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
CA002101310A 1992-07-27 1993-07-26 Novel arylglycinamide derivatives and preparative processes therefor Expired - Fee Related CA2101310C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JPHEI4-219699 1992-07-27
JP21969992 1992-07-27
JP19688293A JP3429338B2 (ja) 1992-07-27 1993-07-14 新規なアリールグリシンアミド誘導体及びその製造法
JPHEI5-196882 1993-07-14

Publications (2)

Publication Number Publication Date
CA2101310A1 CA2101310A1 (en) 1994-01-28
CA2101310C true CA2101310C (en) 2001-07-03

Family

ID=26510045

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002101310A Expired - Fee Related CA2101310C (en) 1992-07-27 1993-07-26 Novel arylglycinamide derivatives and preparative processes therefor

Country Status (11)

Country Link
US (1) US5439919A (es)
EP (1) EP0581167B1 (es)
JP (1) JP3429338B2 (es)
KR (1) KR100295027B1 (es)
AT (1) ATE143943T1 (es)
AU (1) AU658316B2 (es)
CA (1) CA2101310C (es)
DE (1) DE69305276T2 (es)
ES (1) ES2093332T3 (es)
HU (1) HU215846B (es)
TW (1) TW271435B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5706027A (en) * 1985-12-18 1998-01-06 Spacetec Imc Corporation Force and torque converter for use in a computer input device
CA2179574A1 (en) * 1995-06-26 1996-12-27 Tomomi Okada Substituted piperidine derivative and medicine comprising the same
CA2242571C (en) * 1996-08-06 2006-05-16 Taisho Pharmaceutical Co., Ltd. Amino compounds and angiotensin iv receptor agonists
US6620438B2 (en) 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten
DE10143009A1 (de) * 2001-09-03 2003-03-20 Molecular And Clinical Drug Re Präparat zur Behandlung weiblicher Inkontinenz
CN1692401B (zh) * 2002-04-12 2011-11-16 雷斯里·R·奥柏梅尔 多轴输入转换器装置和摇杆
MXPA05000434A (es) 2002-07-08 2005-04-19 Ranbaxy Lab Ltd Derivados de hexano [3.1.0] azabiciclo 3,6-disustituido utiles como antagonistas de receptor muscarinico.
US7265147B2 (en) 2002-07-31 2007-09-04 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
AU2002321711A1 (en) 2002-08-09 2004-02-25 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives useful as muscarinic receptor antagonist
DE60231341D1 (de) 2002-08-23 2009-04-09 Ranbaxy Lab Ltd Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten
EP1572648B1 (en) 2002-12-10 2008-07-09 Ranbaxy Laboratories, Ltd. 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists
WO2004056767A1 (en) 2002-12-23 2004-07-08 Ranbaxy Laboratories Limited 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
US7501443B2 (en) 2002-12-23 2009-03-10 Ranbaxy Laboratories Limited Flavaxate derivatives as muscarinic receptor antagonists
US7488748B2 (en) 2003-01-28 2009-02-10 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
WO2004089898A1 (en) 2003-04-09 2004-10-21 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
BR0318242A (pt) 2003-04-10 2006-04-04 Ranbaxy Lab Ltd derivados de azabiciclo hexano substituìdo como antagonistas de receptores muscarìnicos e processo para sua preparação
EP1615887A1 (en) 2003-04-10 2006-01-18 Ranbaxy Laboratories, Ltd. Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
CN100436414C (zh) 2003-04-11 2008-11-26 兰贝克赛实验室有限公司 作为毒蕈碱受体拮抗剂的氮杂双环衍生物
WO2005100325A1 (en) * 2004-04-14 2005-10-27 Astrazeneca Ab Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
EP1889612A3 (en) * 2006-07-24 2008-03-19 Jan Kees Piet Bruinstroop Method for controlling micturition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1269556A (fr) * 1956-05-14 1961-08-18 Upjohn Co Procédé de préparation de nu-mono-substituées-alpha-(tertio-aminoalcoyl)-alphaphénylacétamides
US4783537A (en) * 1985-11-13 1988-11-08 Pennwalt Corporation α-(aminoalkyl)-arylacetic acid derivatives
JPH0783006B2 (ja) * 1987-12-23 1995-09-06 株式会社半導体エネルギー研究所 薄膜加工方法
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia

Also Published As

Publication number Publication date
HUT64944A (en) 1994-03-28
HU215846B (hu) 1999-04-28
DE69305276D1 (de) 1996-11-14
EP0581167A1 (en) 1994-02-02
DE69305276T2 (de) 1997-04-30
JP3429338B2 (ja) 2003-07-22
ATE143943T1 (de) 1996-10-15
EP0581167B1 (en) 1996-10-09
KR940005534A (ko) 1994-03-21
TW271435B (es) 1996-03-01
US5439919A (en) 1995-08-08
KR100295027B1 (ko) 2001-09-17
ES2093332T3 (es) 1996-12-16
HU9302090D0 (en) 1993-10-28
AU4216993A (en) 1994-02-03
AU658316B2 (en) 1995-04-06
CA2101310A1 (en) 1994-01-28
JPH0692921A (ja) 1994-04-05

Similar Documents

Publication Publication Date Title
CA2101310C (en) Novel arylglycinamide derivatives and preparative processes therefor
US9771376B2 (en) N-substituted benzamides and methods of use thereof
EP1192122B1 (fr) Derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant
WO2003084943A9 (fr) Derives de terphenyle, leur preparation, les compositions pharmaceutiques en contenant
AU603137B2 (en) Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system containing the same
US20040106611A1 (en) N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
MXPA03006597A (es) Derivados de glutaramida sustituida con n-fenpropilciclopentilo como inhibidores de nep para fsad.
WO1996014297A1 (fr) Nouveaux derives de lactame
JP2009007258A (ja) Ｐａｉ−１産生抑制作用を有する３−アニリノ−２−シクロアルケノン誘導体
EP1572648B1 (en) 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists
IE47721B1 (en) New derivatives of 1-azabicyclo(2.2.2)octane,process for their preparation,their use as medicaments and intermediates for their preparation
SK9812002A3 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives
EP1196403B1 (fr) N-aralkyl amines cycliques antipsychotiques
FR2876691A1 (fr) Derives de pyridine, leur preparation, leur application en therapeutique
CA2217479C (en) Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them
AU660832B2 (en) Tetrahydronaphthalene derivatives, their preparation and their application in therapy
US6433174B1 (en) Process for producing novel naphthyridine derivatives
FR2555580A1 (fr) Nouveaux composes azabicycliques, procede pour les preparer et medicaments les contenant
EP0406111B1 (fr) Arylamines et hétéroarylamines substituées, leur procédé de préparation et composition pharmaceutique les contenant
JP6176615B2 (ja) 新規化合物及び抗がん剤
CN1042728C (zh) 芳基甘氨酰胺衍生物及其制备方法
WO1994006773A1 (en) Azepine derivative, production thereof, and use thereof
Dixon Part I: the synthesis of C3 heteroadamantyl cannabinoids Part II: the synthesis of C3 heteroaroyl cannabinoids
UA76491C2 (en) Cyclohexyl sulphones
JPS59515B2 (ja) Ｎ− （ １− アダマンチルメチル ） − ピペラジンノ セイゾウホウ

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed